dr. leonard on the fda approval of tazemetostat in follicular lymphoma
Published 4 years ago • 485 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
8:58
john p. leonard, md, on the fda approval of tazemetostat for follicular lymphoma
-
0:57
dr. skarbnik on the approval of tazemetostat in relapsed/refractory follicular lymphoma
-
3:55
accelerated approval of tazemetostat for follicular lymphoma
-
1:11
dr. maddocks on the role of tazemetostat in ezh2-mutant follicular lymphoma
-
1:31
dr. leonard on lenalidomide with rituximab in follicular lymphoma
-
1:04
dr. leonard on treating relapsed patients with follicular lymphoma
-
1:33
dr. john leonard on treatment options for relapsed follicular lymphoma
-
1:15
dr. leslie on phase 1b trial of tazemetostat plus lenalidomide/rituximab in follicular lymphoma
-
1:06
dr. john leonard on treatment options in follicular lymphoma
-
1:35
dr. burke on tazemetostat’s mechanism of action in ezh2-mutated follicular lymphoma
-
1:06
dr. flinn on the fda approval of duvelisib in cll and follicular lymphoma
-
1:07
dr. john leonard on when to treat patients with follicular lymphoma
-
11:13
fda approval in cll and fl, partial hold lifted in tazmetostat trials, and more
-
6:17
novel therapies for the treatment of follicular lymphoma
-
1:08
dr. skarbnik on future combination therapies with tazemetostat in follicular lymphoma
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
0:46
dr. hill on the fda approval of selinexor in dlbcl
-
4:54
diagnosis and prognosis of follicular lymphoma
-
5:52
r2-chop for relapsed follicular lymphoma